Evotec : EVT801 pre-clinical data published in peer-reviewed cancer research journal

Sydney, Australia, 01 December 2022:
Evotec partner Kazia Therapeutics Limited , an oncology-focused drug development company, announced the publication of positive... | December 2, 2022

Related Keywords

Australia ,United States ,Sydney ,New South Wales ,American , ,Kazia Therapeutics Limited ,University Cancer Institute Of Toulouse ,Cancer Research Communications ,American Association Of Cancer Research ,Nasdaq ,Michael Paillasse ,University Cancer Institute ,American Association ,Cancer Research ,Evotec Se Stock Exchange ,News ,Information ,Press Release ,1 ,December ,Evotec ,Partner ,Azia ,Herapeutics ,Imited ,N ,Drug ,Development ,Nnounced ,The ,Publication ,F Evt De0005664809 ,